PORKEROpen the app

House bill · 119th Congress · Latest step: Introduced

Biosimilars Access and Affordability Act

H.R. 10628Introduced Sep 28, 2026Policy area: Health

Official title: To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.

Open in Bill Explorer →

Where it went

Latest action: Sep 28, 2026 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Cost and committee reports

Official records Congress.gov attaches to H.R. 10628.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of October 23, 2026). Not every bill gets one.

From the Congress.gov bill record for H.R. 10628, last updated October 23, 2026. PORKER’s copy was retrieved October 23, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.

Vote results

No recorded roll-call votes on this bill in PORKER’s records (voice votes and unanimous consent are not roll calls; roll-call records start in 2011).

Cosponsors

8 cosponsors — 3 Republicans, 5 Democrats

5 of 8 cosponsors (62%) are from the other party.

Jake Auchincloss (D-MA), John Joyce (R-PA), Nathaniel Moran (R-TX), Kevin Mullin (D-CA), Jimmy Panetta (D-CA), Scott Peters (D-CA), Linda Sánchez (D-CA), Rudy Yakym (R-IN).

More from the sponsor

Other 119th Congress bills sponsored by Rep. Nicholas Langworthy.

Related bills

Relationships as recorded by Congress.gov.

Sponsor’s state and district

New York in Congress · NY-23 district

Open in Bill Explorer →

Data as of Oct 23, 2026 · bill record checked by PORKER from Congress.gov · votes from Senate.gov and the House Clerk. PORKER is non-partisan.